NCT00028756View on ClinicalTrials.gov

Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium

PHASE3CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

October 31, 2001

Primary Completion Date

January 31, 2014

Study Completion Date

July 31, 2014

Conditions
Stage III Bladder CancerStage IV Bladder CancerTransitional Cell Carcinoma of the Bladder
Interventions
DRUG

doxorubicin hydrochloride

Given IV

DRUG

gemcitabine hydrochloride

Given IV

DRUG

vinblastine sulfate

Given IV

DRUG

methotrexate

Given IV

DRUG

cisplatin

Given IV

BIOLOGICAL

filgrastim

Given SC

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Groupe D'Etude des Tumeurs Uro-Genitales

OTHER

collaborator

Institute of Cancer Research, United Kingdom

OTHER

collaborator

NCIC Clinical Trials Group

NETWORK

collaborator

Arbeitsgemeinschaft Urologische Onkologie

OTHER

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00028756 - Comparison of Immediate and Delayed Adjuvant Chemotherapy in Treating Patients Who Have Undergone a Radical Cystectomy for Stage III or Stage IV Transitional Cell Carcinoma of the Bladder Urothelium | Biotech Hunter | Biotech Hunter